Pharma-Bio Serv (OTCMKTS:PBSV – Get Free Report) issued its earnings results on Monday. The company reported $0.37 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.35, reports. The company had revenue of $2.47 million during the quarter, compared to the consensus estimate of $2.70 million. Pharma-Bio Serv had a negative net margin of 8.18% and a negative return on equity of 5.61%.
Pharma-Bio Serv Stock Performance
Shares of PBSV opened at $0.55 on Tuesday. The business’s 50 day moving average is $0.55 and its 200 day moving average is $0.57. Pharma-Bio Serv has a 12-month low of $0.31 and a 12-month high of $0.90. The company has a market capitalization of $12.61 million, a PE ratio of -18.33 and a beta of 0.53.
Pharma-Bio Serv Announces Dividend
The firm also recently announced a dividend, which will be paid on Thursday, March 20th. Investors of record on Friday, February 28th will be given a dividend of $0.075 per share. The ex-dividend date of this dividend is Friday, February 28th. Pharma-Bio Serv’s dividend payout ratio is currently -250.00%.
Pharma-Bio Serv Company Profile
Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies.
Featured Stories
- Five stocks we like better than Pharma-Bio Serv
- Comparing and Trading High PE Ratio Stocks
- Southwest Airlines Could Triple From Here—Here’s How
- Why Are These Companies Considered Blue Chips?
- Salesforce: An Early AI Opportunity With Long-Term Potential
- What Are Dividend Achievers? An Introduction
- Taiwan Semiconductor Valuation: How Realistic Is the Price?
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.